Substance Use Disorder Linked to Increased Risk for COVID-19
Substance use disorder is associated with a higher risk for COVID-19 than that seen in the general population, as well as worse outcomes.
Pain Management
Vaccine Campaign Would Take 6 to 9 Months to Curb COVID-19
When a safe and effective vaccine against COVID-19 becomes available, it is likely to take 6 to 9 months to have a significant impact.
The Accreditation Association for Ambulatory Health Care Releases Pain Management Toolkit
The AAAHC developed the toolkit as an informational resource for managing pain in both primary care and surgical practices.
Widespread Avoidance of Medical Care Found Due to COVID-19 Concerns
There was widespread reporting of avoidance of medical care due to COVID-19-related concerns in June 2020.
Ethical Considerations When Prescribing Unproven Therapies for COVID-19
Meeting public demand for an urgently needed effective medication quickly and safely during a pandemic involves difficult tradeoffs.
Spotlight on Fibromyalgia: Updates on Diagnosis and Clinical Management
Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, sleep disturbance, fatigue.
Amisulpride Postoperative Nausea, Vomiting Drug Launched
Barhemsys, a selective dopamine-2 and dopamine-3 receptor antagonist, is indicated for the prevention of postoperative nausea and vomiting.
ACIP: Influenza Vaccination Recommendations for 2020-2021
Influenza vaccination should occur by the end of October, if possible.
Self-Reported Prescription Opioid Use During Pregnancy
The CDC analyzed prescription opioid use during pregnancy via a self-reported survey.
Risk for Cannabis Use Increased Among Adults With Depression
Individuals with depression are at a higher risk for cannabis use, with use significantly increased since 2005.
-
Loading...
-
Loading...
Next post in General Pain
